Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Biochemical Reagents
  4. Peptides
  5. NB398596

Novus Biologicals™ LC3B Antibody Blocking Peptide
SDP

Catalog No. NB398596 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.1 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NB398596 0.1 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NB398596 Supplier Novus Biologicals™ Supplier No. NB6001384PEP
Add to Cart
Add to Cart

Specifications

Gene ID (Entrez) 81631
Concentration 1 mg/mL
Content And Storage Store at -80°C. Avoid freeze/thaw cycles.
For Use With (Application) This Peptide is Useful as a Blocking Peptide for NB600-1384
Gene Alias ATG8F, Autophagy-related protein LC3 B, Autophagy-related ubiquitin-like modifier LC3 B, LC3B, lc3b autophagy marker, lc3-i, ii, MAP1 light chain 3-like protein 2, MAP1A/1 BLC3, MAP1A/MAP1B LC3 B, map1lc3b, MAP1LC3B-a, microtubule associated protein 1 light chain 3 beta, microtubule associated protein 3 b, microtubule associated protein 3 beta, microtubule-associated proteins 1 A/1 B light chain 3, microtubule-associated proteins 1 A/1 B light chain 3 B
Gene Symbol MAP1LC3B
Quantity 0.1 mg
Research Category Autophagy, Cancer, Cardiovascular Biology, Cellular Markers, Hypoxia, Innate Immunity, Lipid and Metabolism, Macroautophagy, Neuroscience
Storage Buffer Peptide dissolved in dH20. Contains no BSA.
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.